Welcome to Labeled Immunoassays and Clinical Medicine website!

Clinical Value of Cystatin C in 131I Treatment of Patients with Hyperthyroidism

Expand
  • Department of Nuclear Medicine, Panzhihua Central Hospital, Sichuan 617067, China

Received date: 2013-10-20

  Revised date: 2013-12-26

  Online published: 2014-02-24

Abstract

objective To investigate the clinical value of cystatin C in 131I treatment of patients with hyperthyroidism. Methods The thyroid hormone level and serum level of Cys C and Cr in 43 patients with hyperthyroidism before and after 3 and 6 months of 131I treatment and in 40 healthy controls were determined. Results The serum Cys C levels in patients with hypothyroidism were higher than that of healthy controls. The thyroid hormone level in patients with hypothyroidism were back to normal and serum Cys C levels were decreased after 131I treatment (P<0.05).Conclusion Cystatin C can be the auxiliary diagnostic examination item of hyperthyroidism and could be acted as an auxiliary diagnosis index of efficacy evaluation after 131I treatment.

Cite this article

WU Jie, XU Ying, XU Xiao-hui . Clinical Value of Cystatin C in 131I Treatment of Patients with Hyperthyroidism[J]. Labeled Immunoassays and Clinical Medicine, 2014 , 21(1) : 31 -32 . DOI: 10.11748/bjmy.issn.1006-1703.2014.01.010

Outlines

/